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Speech sound disorders (SSD) are the most common childhood communication impairment, affecting 
approximately 8% of children worldwide. Children with SSD have a difficulty producing clear 
speech, making them difficult to understand and potentially leading to miscommunication and 
frustration. These children are at a high risk of bullying, literacy difficulties, and poor academic 
achievement. It is thus imperative that children receive effective treatment to mitigate these negative 
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errors. Current assessment methods rely on the auditory skills of the assessing speech and language 
therapist (SLT) to perceive and correctly identify speech errors. This is problematic, as perception-
based assessment and transcription of disordered speech is unreliable and at times inaccurate. Further, 
children with persistent SSDs may have covert speech errors that can only be identified with 
instrumental techniques. Incorrect transcription and identification of these errors can result in 
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outcomes. One solution to overcoming these barriers is to use ultrasound imaging as an objective 
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effectiveness of using ultrasound imaging of the tongue for accurate assessment of cKLOGUHQ¶VVSHHFK
leading to appropriate treatment decision-making and efficient therapy. However, as the technology 
currently stands, such analysis is time-consuming (and often only able to be completed using 
specialist software in a university lab) and thus impractical for clinical use. The Ultrax2020 project 
aims to overcome these barriers by employing novel computational methods to develop an ultrasound-
based diagnostic assessment for identifying and categorising speech errors in children with SSD. Over 
the three-year project, SLTs working across Scotland will assess the speech of 120 children aged 5 to 
18 with SSD. Where appropriate, these children will also receive treatment from their NHS SLT using 
ultrasound visual biofeedback. The efficacy of using ultrasound as a form of visual biofeedback in 
intervention for persistent and residual SSD in tightly-controlled contexts is well established, but to 
date no research has explored its effectiveness in everyday clinical contexts. Data collected from 
assessment and intervention sessions will be sent to the research team for detailed analysis, including 
phonetic transcription, and qualitative and quantitative ultrasound measures. Changes to the 
ultrasound software will be made throughout the project to further improve the accuracy of on-line 
analysis completed by SLTs in the clinic. Additionally, the effectiveness of ultrasound visual 
biofeedback in the assessment and treatment of SSD will be investigated, to provide preliminary 
information for large-scale clinical trials in the future. The overall aim of the Ultrax2020 project is to 
develop and improve ultrasound as a powerful tool for the accurate and differential diagnosis of 
childhood SSD. By doing this, speech therapy can be optimised to suit each individual child, leading 
to more efficient outcomes for children with SSD. 
